Form 8-K - Current report:
SEC Accession No. 0000950170-22-011815
Filing Date
2022-06-17
Accepted
2022-06-17 16:18:17
Documents
12
Period of Report
2022-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K onct-20220616.htm   iXBRL 8-K 77548
  Complete submission text file 0000950170-22-011815.txt   196644

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT onct-20220616.xsd EX-101.SCH 2467
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT onct-20220616_pre.xml EX-101.PRE 10944
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT onct-20220616_lab.xml EX-101.LAB 13752
6 EXTRACTED XBRL INSTANCE DOCUMENT onct-20220616_htm.xml XML 4715
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

EIN.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 221024095
SIC: 2834 Pharmaceutical Preparations